[The ODYSSEY OUTCOMES trial]

G Ital Cardiol (Rome). 2019 Apr;20(4):187-189. doi: 10.1714/3126.31069.
[Article in Italian]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Humans
  • Hypercholesterolemia / complications
  • Hypercholesterolemia / drug therapy*
  • Randomized Controlled Trials as Topic
  • Risk Factors

Substances

  • Antibodies, Monoclonal, Humanized
  • alirocumab